Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone Effects on MMPs in Chronic Heart Failure
NCT00663195Phase 4Completed
- Sponsor
- Tottori University Hospital
- Start
- Jan 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of spironolactone in chronic heart failure (CHF) (2 arms), sponsored by Tottori University Hospital. Primary endpoint: Matrix Metalloproteinase levels at 16 weeks. Started Jan 2004; status: completed.
02
Drugs
spironolactone
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00663195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00663195.